Discover this podcast and so much more

Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

Recently Approved Drugs: Pembrolizumab for cHL

Recently Approved Drugs: Pembrolizumab for cHL

FromASCO Education


Recently Approved Drugs: Pembrolizumab for cHL

FromASCO Education

ratings:
Length:
5 minutes
Released:
Nov 11, 2017
Format:
Podcast episode

Description

Dr. Christina Wiedl, director of the pediatric and young adult stem cell transplant program at Virginia Commonwealth University, presents information on the recently approved drug in oncology, keytruda for relapsed and refractory classical Hodgkin lymphoma in pediatric and young adult patients.
Released:
Nov 11, 2017
Format:
Podcast episode

Titles in the series (100)

The ASCO Education Podcast features expert conversations on the most talked-about topics in oncology today from physician burnout, medical cannabis, COVID and cancer and more…